Sponsored
ALOY's rare earth expertise, built over 40 yrs, offers a unique moat. Rebuilding this is costly & time-consuming.
GILD beats Q1 revenue, but full-year EPS guidance plunges on acquisition costs. HIV & oncology shine.
PTEN director sells $123K shares, keeps $961K. Open market sale, not a 10b5-1 plan.
Trump delays beef tariff cut after rancher and Republican pushback Earlier reports were that Trump was planning lowering levies as part of larger affordability push.
PBOC is expected to set the USD/CNY reference rate at 6.7945 – Reuters estimate
Robinhood's RVI fund doubled investor returns; RVII targets early-stage startups with higher risk/reward.
FOUR beats revenue but slashes full-year guidance. Growth slows, but margins expand. Is it a buy?
Sponsored